DOSSIER · 13F Holders · Q3 2025Healthcare · Biotechnology
AKRO
AKERO THERAPEUTICS INC
5 institutions still hold AKERO THERAPEUTICS INC as of Q3 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 00973Y108·Biotechnology·5 13F holders·last filed Sep 30, 2025
AI Holders Summary · Q3 2025
5 institutions reported AKRO in Q3 2025. AXA Investment Managers S.A. leads at 75.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.